© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Sydney Jennings
Articles
COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types
October 09, 2024
Prior SARS-CoV-2 infection was associated with a 2-fold increased risk for MACE for up to 3 years, even among people with no history of CVD, in a new analysis of UK Biobank data.
Preconception Prediabetes in Young Women and Adverse Birth Outcomes: Daily Dose
October 09, 2024
Your daily dose of the clinical news you may have missed.
Survodutide Wins FDA Breakthrough Therapy Designation for Noncirrhotic MASH Treatment in Adults
October 08, 2024
The safety and efficacy of survodutide in patients with MASH and fibrosis will be assessed in a global pair of phase 3 trials.
FDA Approves First-Ever Biologic Medicine for COPD: Daily Dose
October 08, 2024
Your daily dose of the clinical news you may have missed.
Menopausal VMS Education in Primary Care: Build Trust First, Says One Clinician
October 08, 2024
Building trust with patients early on will help them feel comfortable discussing their symptoms and treatment preferences, says JoAnn Pinkerton, MD.
Flu Vaccine Reduced Related Hospitalizations by About One-Third in Southern Hemisphere, but Uptake Still Low
October 07, 2024
Less than one-quarter of people infected with influenza-associated severe acute respiratory illness were vaccinated, according to a new report.
Menopausal Vasomotor Symptoms: Clinician and Patients Both Need Education, Expert Says
October 07, 2024
Less than 15% of women in menopause receive treatment for VMS, suggesting a need a for more education and awareness, according to JoAnn Pinkerton, MD.
FDA Approves First-in-Class Schizophrenia Drug: Daily Dose
October 07, 2024
Your daily dose of the clinical news you may have missed.
US Colorectal Cancer Screening Increased Three-Fold among Adults Aged 45-49 Years, but Disparities Persist
October 04, 2024
Increases in CRC screening were higher in high socioeconomic status and metropolitan areas, according to a new large cohort study.
Switching from HRT to Non-HRT: Safety Considerations for Menopausal Women
October 04, 2024
An expert discussion with JoAnn Pinkerton, MD, national lead for the OASIS clinical trial program of elinzanetant for moderate-to-severe VMS.